Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis

In the present study, we investigated the in vitro and in vivo leishmanicidal activity of synthetic compounds, containing a semicarbazone scaffold as a peptide mimetic framework. The leishmanicidal effect against amastigotes of Leishmania amazonensis was also evaluated at concentration of 100 μM–0.0...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental parasitology 2019-06, Vol.201, p.57-66
Hauptverfasser: Cavalcanti de Queiroz, Aline, Alves, Marina Amaral, Barreiro, Eliezer Jesus, Lima, Lídia Moreira, Alexandre-Moreira, Magna Suzana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 66
container_issue
container_start_page 57
container_title Experimental parasitology
container_volume 201
creator Cavalcanti de Queiroz, Aline
Alves, Marina Amaral
Barreiro, Eliezer Jesus
Lima, Lídia Moreira
Alexandre-Moreira, Magna Suzana
description In the present study, we investigated the in vitro and in vivo leishmanicidal activity of synthetic compounds, containing a semicarbazone scaffold as a peptide mimetic framework. The leishmanicidal effect against amastigotes of Leishmania amazonensis was also evaluated at concentration of 100 μM–0.01 nM. The derivatives 2e, 2f, 2g and 1g, beyond the standards miltefosine and pentamidine, significantly diminished the number of L. amazonensis amastigotes in macrophages. These derivatives were also active against amastigotes of L. braziliensis. As 2g presented potent leishmanicidal activity against the amastigotes of L. amazonensis in macrophages, we also investigated the in vivo leishmanicidal activity of this compound against L. amazonensis. Approximately 105L. amazonensis promastigotes were subcutaneously inoculated into the dermis of the right ear of BALB/c mice, which were subsequently treated with 2g (p.o. or i.p.), miltefosine (p.o.) or glucantime (i.p.) at 30 μmol/kg/day x 28 days. Thus, a similar reduction in the lesion size was observed after the administration of 2g through oral (63.7 ± 10.1%) and intraperitoneal (61.8 ± 3.7%) routes. A larger effect was observed after treatment with miltefosine (97.7 ± 0.4%), and glucantime did not exhibit activity at the dose administered. With respect to the ear parasite load, 2g diminished the number of parasites by p.o. (30.5 ± 5.1%) and i.p. (33.3 ± 4.3%) administration. In addition, 2g induced in vitro apoptosis, autophagy and cell cycle alterations on L. amazonensis promastigotes. In summary, the derivative 2g might represent a lead candidate for antileishmanial drugs, as this compound displayed pronounced leishmanicidal activity. [Display omitted] •Semicarbazone were evaluated in vitro against L. amazonensis and L.braziliensis.•L. amazonensis and L.braziliensis were susceptible to 2g (LASSBIO-1483).•2g induced in vitro apoptosis, autophagy and cell cycle arrest on L. amazonensis.•2g presented leishmanicidal activity against L. amazonensis.
doi_str_mv 10.1016/j.exppara.2019.04.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2211949029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014489418303850</els_id><sourcerecordid>2211949029</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-ee3172fdec57026c3256afa64c3d0fa798d41de399ebe8f96c40716944e3ddb33</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EoqXwCaAs2SSMH0nqFUIVL6kSSMDacuwJdZUXdloBX0-qBrasZnNm7p1DyDmFhALNrtYJfnad9jphQGUCIgHgB2RKQULMhJCHZApARSzmUkzISQhrAJhTJo7JhFMAkeZ0Sp5fsHZG-0J_tw1GFr3b6t5tMUQ6RJ1vaxdc8x71K_S6w03vTKSrHn0zUq6JKnRhVevG6eDCKTkqdRXwbJwz8nZ3-7p4iJdP94-Lm2VseJb2MSKnOSstmjQHlhnO0kyXOhOGWyh1LudWUItcSixwXsrMCMhpJoVAbm3B-Yxc7u8OHT82GHo1NDVYVbrBdhMUY5RKIYHJAU33qPFtCB5L1XlXa_-lKKidTLVWo0y1k6lAqEHmsHcxRmyKGu3f1q-9AbjeAzg8unXoVTAOG4PWeTS9sq37J-IHUxWKRA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2211949029</pqid></control><display><type>article</type><title>Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><creator>Cavalcanti de Queiroz, Aline ; Alves, Marina Amaral ; Barreiro, Eliezer Jesus ; Lima, Lídia Moreira ; Alexandre-Moreira, Magna Suzana</creator><creatorcontrib>Cavalcanti de Queiroz, Aline ; Alves, Marina Amaral ; Barreiro, Eliezer Jesus ; Lima, Lídia Moreira ; Alexandre-Moreira, Magna Suzana</creatorcontrib><description>In the present study, we investigated the in vitro and in vivo leishmanicidal activity of synthetic compounds, containing a semicarbazone scaffold as a peptide mimetic framework. The leishmanicidal effect against amastigotes of Leishmania amazonensis was also evaluated at concentration of 100 μM–0.01 nM. The derivatives 2e, 2f, 2g and 1g, beyond the standards miltefosine and pentamidine, significantly diminished the number of L. amazonensis amastigotes in macrophages. These derivatives were also active against amastigotes of L. braziliensis. As 2g presented potent leishmanicidal activity against the amastigotes of L. amazonensis in macrophages, we also investigated the in vivo leishmanicidal activity of this compound against L. amazonensis. Approximately 105L. amazonensis promastigotes were subcutaneously inoculated into the dermis of the right ear of BALB/c mice, which were subsequently treated with 2g (p.o. or i.p.), miltefosine (p.o.) or glucantime (i.p.) at 30 μmol/kg/day x 28 days. Thus, a similar reduction in the lesion size was observed after the administration of 2g through oral (63.7 ± 10.1%) and intraperitoneal (61.8 ± 3.7%) routes. A larger effect was observed after treatment with miltefosine (97.7 ± 0.4%), and glucantime did not exhibit activity at the dose administered. With respect to the ear parasite load, 2g diminished the number of parasites by p.o. (30.5 ± 5.1%) and i.p. (33.3 ± 4.3%) administration. In addition, 2g induced in vitro apoptosis, autophagy and cell cycle alterations on L. amazonensis promastigotes. In summary, the derivative 2g might represent a lead candidate for antileishmanial drugs, as this compound displayed pronounced leishmanicidal activity. [Display omitted] •Semicarbazone were evaluated in vitro against L. amazonensis and L.braziliensis.•L. amazonensis and L.braziliensis were susceptible to 2g (LASSBIO-1483).•2g induced in vitro apoptosis, autophagy and cell cycle arrest on L. amazonensis.•2g presented leishmanicidal activity against L. amazonensis.</description><identifier>ISSN: 0014-4894</identifier><identifier>EISSN: 1090-2449</identifier><identifier>DOI: 10.1016/j.exppara.2019.04.003</identifier><identifier>PMID: 31004571</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Apoptosis ; Autophagy ; Leishmania spp ; Leishmaniasis ; Neglected diseases ; Semicarbazone</subject><ispartof>Experimental parasitology, 2019-06, Vol.201, p.57-66</ispartof><rights>2019 Elsevier Inc.</rights><rights>Copyright © 2019 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-ee3172fdec57026c3256afa64c3d0fa798d41de399ebe8f96c40716944e3ddb33</citedby><cites>FETCH-LOGICAL-c365t-ee3172fdec57026c3256afa64c3d0fa798d41de399ebe8f96c40716944e3ddb33</cites><orcidid>0000-0002-6362-2726 ; 0000-0002-9979-1994 ; 0000-0003-1759-0038</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.exppara.2019.04.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31004571$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cavalcanti de Queiroz, Aline</creatorcontrib><creatorcontrib>Alves, Marina Amaral</creatorcontrib><creatorcontrib>Barreiro, Eliezer Jesus</creatorcontrib><creatorcontrib>Lima, Lídia Moreira</creatorcontrib><creatorcontrib>Alexandre-Moreira, Magna Suzana</creatorcontrib><title>Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis</title><title>Experimental parasitology</title><addtitle>Exp Parasitol</addtitle><description>In the present study, we investigated the in vitro and in vivo leishmanicidal activity of synthetic compounds, containing a semicarbazone scaffold as a peptide mimetic framework. The leishmanicidal effect against amastigotes of Leishmania amazonensis was also evaluated at concentration of 100 μM–0.01 nM. The derivatives 2e, 2f, 2g and 1g, beyond the standards miltefosine and pentamidine, significantly diminished the number of L. amazonensis amastigotes in macrophages. These derivatives were also active against amastigotes of L. braziliensis. As 2g presented potent leishmanicidal activity against the amastigotes of L. amazonensis in macrophages, we also investigated the in vivo leishmanicidal activity of this compound against L. amazonensis. Approximately 105L. amazonensis promastigotes were subcutaneously inoculated into the dermis of the right ear of BALB/c mice, which were subsequently treated with 2g (p.o. or i.p.), miltefosine (p.o.) or glucantime (i.p.) at 30 μmol/kg/day x 28 days. Thus, a similar reduction in the lesion size was observed after the administration of 2g through oral (63.7 ± 10.1%) and intraperitoneal (61.8 ± 3.7%) routes. A larger effect was observed after treatment with miltefosine (97.7 ± 0.4%), and glucantime did not exhibit activity at the dose administered. With respect to the ear parasite load, 2g diminished the number of parasites by p.o. (30.5 ± 5.1%) and i.p. (33.3 ± 4.3%) administration. In addition, 2g induced in vitro apoptosis, autophagy and cell cycle alterations on L. amazonensis promastigotes. In summary, the derivative 2g might represent a lead candidate for antileishmanial drugs, as this compound displayed pronounced leishmanicidal activity. [Display omitted] •Semicarbazone were evaluated in vitro against L. amazonensis and L.braziliensis.•L. amazonensis and L.braziliensis were susceptible to 2g (LASSBIO-1483).•2g induced in vitro apoptosis, autophagy and cell cycle arrest on L. amazonensis.•2g presented leishmanicidal activity against L. amazonensis.</description><subject>Apoptosis</subject><subject>Autophagy</subject><subject>Leishmania spp</subject><subject>Leishmaniasis</subject><subject>Neglected diseases</subject><subject>Semicarbazone</subject><issn>0014-4894</issn><issn>1090-2449</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFkMtOwzAQRS0EoqXwCaAs2SSMH0nqFUIVL6kSSMDacuwJdZUXdloBX0-qBrasZnNm7p1DyDmFhALNrtYJfnad9jphQGUCIgHgB2RKQULMhJCHZApARSzmUkzISQhrAJhTJo7JhFMAkeZ0Sp5fsHZG-0J_tw1GFr3b6t5tMUQ6RJ1vaxdc8x71K_S6w03vTKSrHn0zUq6JKnRhVevG6eDCKTkqdRXwbJwz8nZ3-7p4iJdP94-Lm2VseJb2MSKnOSstmjQHlhnO0kyXOhOGWyh1LudWUItcSixwXsrMCMhpJoVAbm3B-Yxc7u8OHT82GHo1NDVYVbrBdhMUY5RKIYHJAU33qPFtCB5L1XlXa_-lKKidTLVWo0y1k6lAqEHmsHcxRmyKGu3f1q-9AbjeAzg8unXoVTAOG4PWeTS9sq37J-IHUxWKRA</recordid><startdate>20190601</startdate><enddate>20190601</enddate><creator>Cavalcanti de Queiroz, Aline</creator><creator>Alves, Marina Amaral</creator><creator>Barreiro, Eliezer Jesus</creator><creator>Lima, Lídia Moreira</creator><creator>Alexandre-Moreira, Magna Suzana</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6362-2726</orcidid><orcidid>https://orcid.org/0000-0002-9979-1994</orcidid><orcidid>https://orcid.org/0000-0003-1759-0038</orcidid></search><sort><creationdate>20190601</creationdate><title>Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis</title><author>Cavalcanti de Queiroz, Aline ; Alves, Marina Amaral ; Barreiro, Eliezer Jesus ; Lima, Lídia Moreira ; Alexandre-Moreira, Magna Suzana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-ee3172fdec57026c3256afa64c3d0fa798d41de399ebe8f96c40716944e3ddb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Apoptosis</topic><topic>Autophagy</topic><topic>Leishmania spp</topic><topic>Leishmaniasis</topic><topic>Neglected diseases</topic><topic>Semicarbazone</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cavalcanti de Queiroz, Aline</creatorcontrib><creatorcontrib>Alves, Marina Amaral</creatorcontrib><creatorcontrib>Barreiro, Eliezer Jesus</creatorcontrib><creatorcontrib>Lima, Lídia Moreira</creatorcontrib><creatorcontrib>Alexandre-Moreira, Magna Suzana</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental parasitology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cavalcanti de Queiroz, Aline</au><au>Alves, Marina Amaral</au><au>Barreiro, Eliezer Jesus</au><au>Lima, Lídia Moreira</au><au>Alexandre-Moreira, Magna Suzana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis</atitle><jtitle>Experimental parasitology</jtitle><addtitle>Exp Parasitol</addtitle><date>2019-06-01</date><risdate>2019</risdate><volume>201</volume><spage>57</spage><epage>66</epage><pages>57-66</pages><issn>0014-4894</issn><eissn>1090-2449</eissn><abstract>In the present study, we investigated the in vitro and in vivo leishmanicidal activity of synthetic compounds, containing a semicarbazone scaffold as a peptide mimetic framework. The leishmanicidal effect against amastigotes of Leishmania amazonensis was also evaluated at concentration of 100 μM–0.01 nM. The derivatives 2e, 2f, 2g and 1g, beyond the standards miltefosine and pentamidine, significantly diminished the number of L. amazonensis amastigotes in macrophages. These derivatives were also active against amastigotes of L. braziliensis. As 2g presented potent leishmanicidal activity against the amastigotes of L. amazonensis in macrophages, we also investigated the in vivo leishmanicidal activity of this compound against L. amazonensis. Approximately 105L. amazonensis promastigotes were subcutaneously inoculated into the dermis of the right ear of BALB/c mice, which were subsequently treated with 2g (p.o. or i.p.), miltefosine (p.o.) or glucantime (i.p.) at 30 μmol/kg/day x 28 days. Thus, a similar reduction in the lesion size was observed after the administration of 2g through oral (63.7 ± 10.1%) and intraperitoneal (61.8 ± 3.7%) routes. A larger effect was observed after treatment with miltefosine (97.7 ± 0.4%), and glucantime did not exhibit activity at the dose administered. With respect to the ear parasite load, 2g diminished the number of parasites by p.o. (30.5 ± 5.1%) and i.p. (33.3 ± 4.3%) administration. In addition, 2g induced in vitro apoptosis, autophagy and cell cycle alterations on L. amazonensis promastigotes. In summary, the derivative 2g might represent a lead candidate for antileishmanial drugs, as this compound displayed pronounced leishmanicidal activity. [Display omitted] •Semicarbazone were evaluated in vitro against L. amazonensis and L.braziliensis.•L. amazonensis and L.braziliensis were susceptible to 2g (LASSBIO-1483).•2g induced in vitro apoptosis, autophagy and cell cycle arrest on L. amazonensis.•2g presented leishmanicidal activity against L. amazonensis.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31004571</pmid><doi>10.1016/j.exppara.2019.04.003</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-6362-2726</orcidid><orcidid>https://orcid.org/0000-0002-9979-1994</orcidid><orcidid>https://orcid.org/0000-0003-1759-0038</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0014-4894
ispartof Experimental parasitology, 2019-06, Vol.201, p.57-66
issn 0014-4894
1090-2449
language eng
recordid cdi_proquest_miscellaneous_2211949029
source Elsevier ScienceDirect Journals Complete - AutoHoldings
subjects Apoptosis
Autophagy
Leishmania spp
Leishmaniasis
Neglected diseases
Semicarbazone
title Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T15%3A59%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Semicarbazone%20derivatives%20as%20promising%20therapeutic%20alternatives%20in%20leishmaniasis&rft.jtitle=Experimental%20parasitology&rft.au=Cavalcanti%20de%20Queiroz,%20Aline&rft.date=2019-06-01&rft.volume=201&rft.spage=57&rft.epage=66&rft.pages=57-66&rft.issn=0014-4894&rft.eissn=1090-2449&rft_id=info:doi/10.1016/j.exppara.2019.04.003&rft_dat=%3Cproquest_cross%3E2211949029%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2211949029&rft_id=info:pmid/31004571&rft_els_id=S0014489418303850&rfr_iscdi=true